Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Specific IgA against Pseudomonas aeruginosa in severe COPD

  • Millares, Laura|||0000-0002-0242-0274
  • Marti, Sara|||0000-0002-0405-2305
  • Ardanuy, Carmen|||0000-0003-0225-607X
  • Liñares, Josefina
  • Santos, Salud|||0000-0002-5835-1028
  • Dorca, Jordi|||0000-0002-8137-878X
  • Garcia-Nuñez, Marian|||0000-0002-5158-3758
  • Quero, Sara|||0000-0002-6454-6358
  • Monsó, Eduard
The bronchial mucosa is protected by a specialized immune system focused on the prevention of colonization and infection by potentially pathogenic microorganisms (PPMs). Immunoglobulin A (IgA) is the principal antibody involved in this mechanism. A defective immune barrier may facilitate the recurrent presence of PPMs in COPD. The aim of this study was to determine IgA-mediated bronchial specific immune responses against Pseudomonas aeruginosa in stable patients with severe disease. COPD patients with good-quality sputum samples obtained during stability were included and classified according to the presence or absence of chronic bronchial colonization by P. aeruginosa. Levels of specific IgA for P. aeruginosa in sputum were determined by ELISA and expressed as ratios, using the pooled level of 10 healthy subjects as reference (optical density patient/control). Thirty-six stable COPD patients were included, 15 of whom had chronic colonization by P. aeruginosa. Levels of specific IgA against P. aeruginosa in stable non-colonized patients were lower than those in healthy subjects (IgA ratio: median =0.15 [interquartile range {IQR} 0.05-0.36]). Colonized patients had higher levels, (1.56 [IQR 0.59-2.79]) (p 0.001, Mann-Whitney U test), with figures equivalent but not exceeding the reference value. IgA-based immune response against P. aeruginosa was low in severe COPD patients. Levels of specific IgA against this microorganism were higher in colonized patients, but did not attain clear-cut levels above the reference. An impaired local response against P. aeruginosa may favor chronic colonization and recurrent infections in severe COPD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain

  • Càmara, Jordi|||0000-0002-0817-0931
  • Marimón, José María|||0000-0002-2787-7094
  • Cercenado, Emilia|||0000-0002-5279-3773
  • Larrosa, María Nieves|||0000-0001-8808-0233
  • Quesada, Maria Dolores|||0000-0001-8360-3787
  • Fontanals, Dionísia|||0000-0002-2994-6065
  • Cubero, Meritxell
  • Pérez Trallero, Emilio
  • Fenoll, Asunción
  • Liñares, Josefina
  • Ardanuy, Carmen|||0000-0003-0225-607X
A prospective laboratory-based multicenter study that collected all adult invasive pneumococcal disease (IPD) episodes from 6 Spanish hospitals before (2008±2009) and after (2012±2013). The 13-valent pneumococcal conjugate vaccine (PCV13) licensure was conducted in order to analyze the impact of PCV13 introduction for children on adult IPD. A total of 1558 IPD episodes were detected. The incidence of IPD decreased significantly in the second period by -33.9% (95% CI, -40.3% to -26.8%). IPD due to PCV7 serotypes (-52.7%; 95% CI, -64.2% to -37.5%) and to PCV13 additional serotypes (-55.0% 95% CI, -62.0% to -46.7%) significantly decreased whereas IPD due to non-PCV13 serotypes remained stable (1.0% 95% CI, -12.9% to 17.2%). IPD due to all PCV13 additional serotypes significantly declined with the exception of serotype 3 (-11.3%; 95%CI -35.0% to 21.1%). IPD due to two non-PCV13 serotypes varied: serotype 6C that rose (301.6%; 95% CI, 92.7% to 733.3%, p<0.001), related to the expansion of ST3866C, and serotype 8 that decreased (-34.9%, 95%CI, -57.1 to -1.2, p = 0.049), related to a decline of the ST638. The recombinant clone ST652111A (variant of ST1569V) increased in frequency. The decrease of serotype 19A IPD was linked to a fall in those antibiotic susceptible clones. In the last period, rates of penicillin- and cefotaxime-resistance remained under 10% and 4%, respectively. Adult IPD decreased after the PCV13 introduction in Spain due to herd protection. The spread of multidrug resistant clones (ST3866C, ST652111A) related to non-PCV13 serotypes needs further surveillance.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Urban Wild Boars and Risk for Zoonotic Streptococcus suis, Spain

  • Fernández Aguilar, Xavier|||0000-0002-4939-6048
  • Gottschalk, Marcelo|||0000-0002-2196-2212
  • Aragón, Virginia|||0000-0002-3470-6015
  • Càmara, Jordi|||0000-0002-0817-0931
  • Ardanuy, Carmen|||0000-0003-0225-607X
  • Velarde, Roser|||0000-0003-3332-6405
  • Galofré Milà, Núria
  • Castillo Contreras, Raquel|||0000-0002-5770-7264
  • López Olvera, Jorge R.|||0000-0002-2999-3451
  • Mentaberre García, Gregorio|||0000-0001-9542-7514
  • Colom Cadena, Andreu|||0000-0003-0983-2412
  • Lavín González, Santiago|||0000-0001-5655-588X
  • Cabezón Ponsoda, Óscar|||0000-0001-7543-8371
Urban wild boars (Sus scrofa) from Barcelona, Spain, harbor great diversity of Streptococcus suis strains, including strains with the cps2 gene and with the same molecular profile as local human cases. The increasing trend of potential effective contacts for S. suis transmission is of public health concern.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the OVID-19 Pandemic

  • Trevijano-Contador, Nuria
  • Torres-Cano, Alba
  • Carballo-González, Cristina
  • Puig-Asensio, Mireia|||0000-0002-0722-2218
  • Martin-Gomez, M. Teresa|||0000-0001-8119-8749
  • Jiménez-Martínez, Emilio|||0000-0003-2831-037X
  • Romero, Daniel|||0000-0003-4934-2477
  • Nuvials, Xavier|||0000-0002-6648-2394
  • Olmos-Arenas, Roberto
  • Moretó-Castellsagué, María Clara
  • Fernández-Delgado, Lucía|||0000-0001-8815-0967
  • Rodríguez-Sevilla, Graciela
  • Aguilar-Sánchez, María-Mercedes
  • Ayats, Josefina
  • Ardanuy, Carmen|||0000-0003-0225-607X
  • Sánchez Romero, María Isabel
  • Muñoz-Algarra, María
  • Merino-Amador, Paloma
  • González-Romo, Fernando
  • Megías-Lobón, Gregoria
  • García-Campos, Jose Angel
  • Mantecón-Vallejo, María Ángeles
  • Alcoceba, Eva
  • Escribano Martos, Pilar|||0000-0001-6254-4570
  • Guinea, Jesús
  • Durán-Valle, Maria Teresa
  • Fraile-Torres, Arturo
  • Roiz-Mesones, María Pía
  • Lara-Plaza, Isabel
  • de Ayala, Ana Pérez
  • Simón Sacristán, María|||0009-0008-9585-2156
  • Collazos-Blanco, Ana
  • Nebreda-Mayoral, Teresa
  • March-Roselló, Gabriel
  • Alcázar-Fuoli, Laura
  • Zaragoza, Óscar|||0000-0002-1581-0845
Candida parapsilosis is a frequent cause of candidemia worldwide. Its incidence is associated with the use of medical implants, such as central venous catheters or parenteral nutrition. This species has reduced susceptibility to echinocandins, and it is susceptible to polyenes and azoles. Multiple outbreaks caused by fluconazole-nonsusceptible strains have been reported recently. A similar trend has been observed among the C. parapsilosis isolates received in the last 2 years at the Spanish Mycology Reference Laboratory. Yeast were identified by molecular biology, and antifungal susceptibility testing was performed using the European Committee on Antimicrobial Susceptibility Testing protocol. The ERG11 gene was sequenced to identify resistance mechanisms, and strain typing was carried out by microsatellite analysis. We examined the susceptibility profile of 1315 C. parapsilosis isolates available at our reference laboratory between 2000 and 2021, noticing an increase in the number of isolates with acquired resistance to fluconazole, and voriconazole has increased in at least 8 different Spanish hospitals in 2020-2021. From 121 recorded clones, 3 were identified as the most prevalent in Spain (clone 10 in Catalonia and clone 96 in Castilla-Leon and Madrid, whereas clone 67 was found in 2 geographically unrelated regions, Cantabria and the Balearic Islands). Our data suggest that concurrently with the coronavirus disease 2019 pandemic, a selection of fluconazole-resistant C. parapsilosis isolates has occurred in Spain, and the expansion of specific clones has been noted across centers. Further research is needed to determine the factors that underlie the successful expansion of these clones and their potential genetic relatedness.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genetic Adaptation and Acquisition of Macrolide Resistance in spp. during Persistent Respiratory Tract Colonization in Chronic Obstructive Pulmonary Disease (COPD) Patients Receiving Long-Term Azithromycin Treatment

  • Carrera-Salinas, Anna|||0000-0003-4205-1781
  • Gonzalez Diaz, Aida|||0000-0002-8326-1307
  • Ehrlich, Rachel L.
  • Berbel, Dàmaris|||0000-0002-3689-3360
  • Tubau, Fe|||0000-0002-6416-6451
  • Pomares, Xavier|||0000-0002-2783-414X
  • Garmendia, Junkal
  • Domínguez, M. Ángeles
  • Ardanuy, Carmen|||0000-0003-0225-607X
  • Huertas, Daniel
  • Marín, Alicia|||0000-0002-9358-2120
  • Montón, Conchita
  • Mell, Joshua Chang
  • Santos, Salud|||0000-0002-5835-1028
  • Marti, Sara|||0000-0002-0405-2305
Patients with chronic obstructive pulmonary disease (COPD) benefit from the immunomodulatory effect of azithromycin, but long-term administration may alter colonizing bacteria. Our goal was to identify changes in and during azithromycin treatment. Fifteen patients were followed while receiving prolonged azithromycin treatment (Hospital Universitari de Bellvitge, Spain). Four patients (P02, P08, P11, and P13) were persistently colonized by for at least 3 months and two (P04 and P11) by H. parainfluenzae. Isolates from these patients (53 and 18 H. parainfluenzae) were included to identify, by whole-genome sequencing, antimicrobial resistance changes and genetic variation accumulated during persistent colonization. All persistent lineages isolated before treatment were azithromycin-susceptible but developed resistance within the first months, apart from those belonging to P02, who discontinued the treatment. isolates from P08-ST107 acquired mutations in 23S rRNA, and those from P11-ST2480 and P13-ST165 had changes in L4 and L22. In H. parainfluenzae, P04 persistent isolates acquired changes in rlmC, and P11 carried genes encoding MefE/MsrD efflux pumps in an integrative conjugative element, which was also identified in P11-ST147. Other genetic variation occurred in genes associated with cell wall and inorganic ion metabolism. Persistent strains all showed changes in licA and hgpB genes. Other genes (lex1, lic3A, hgpC, and fadL) had variation in multiple lineages. Furthermore, persistent strains showed loss, acquisition, or genetic changes in prophage-associated regions. Long-term azithromycin therapy results in macrolide resistance, as well as genetic changes that likely favor bacterial adaptation during persistent respiratory colonization. IMPORTANCE The immunomodulatory properties of azithromycin reduce the frequency of exacerbations and improve the quality of life of COPD patients. However, long-term administration may alter the respiratory microbiota, such as , an opportunistic respiratory colonizing bacteria that play an important role in exacerbations. This study contributes to a better understanding of COPD progression by characterizing the clinical evolution of in a cohort of patients with prolonged azithromycin treatment. The emergence of macrolide resistance during the first months, combined with the role of as a reservoir and source of resistance dissemination, is a cause for concern that may lead to therapeutic failure. Furthermore, genetic variations in cell wall and inorganic ion metabolism coding genes likely favor bacterial adaptation to host selective pressures. Therefore, the bacterial pathoadaptive evolution in these severe COPD patients raise our awareness of the possible spread of macrolide resistance and selection of host-adapted clones.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Trends in the epidemiology of catheter-related bloodstream infections, towards a paradigm shift, Spain, 2007 to 2019

  • Badia Cebada, Laia|||0000-0002-9321-8492
  • Peñafiel, Judith|||0009-0006-6688-6395
  • Saliba, Patrick
  • Andrés Nieto, Marta|||0000-0001-5267-0039
  • Càmara, Jordi|||0000-0002-0817-0931
  • Domènech, Dolors
  • Jiménez-Martínez, Emili
  • Marrón, Anna
  • Moreno, Encarna
  • Pomar, Virginia|||0000-0002-8473-5834
  • Vaqué, Montserrat
  • Limón, Enric|||0000-0002-5396-1521
  • Masats, Úrsula
  • Pujol, Miquel|||0000-0002-6475-6208
  • Gasch, Oriol|||0000-0001-8518-458X
  • Jover, Alfredo
  • Castellana, Dolors
  • Olona, Montserrat|||0000-0001-5303-9361
  • García Pino, Antonia
  • Rebull Fatsini, Josep|||0000-0002-1460-8290
  • Domènech, Mª France
  • Pujol, Miquel|||0000-0002-6475-6208
  • Hornero, Ana
  • Ardanuy, Carmen|||0000-0003-0225-607X
  • Berbel Palau, Dàmaris
  • López-Contreras, Joaquín|||0000-0002-3166-4016
  • Fernández, Engracia
  • Salgado, Xavier
  • Lérida, Ana
  • Martin, Lydia
  • Sopena, Nieves|||0000-0001-6382-9500
  • Casas, Irma|||0000-0002-5902-5777
  • Pérez, Rafael
  • Maraver, Encarna
  • Palau, Eva
  • Serrats, Pepi
  • Martinez Martinez, Jose Antonio|||0000-0002-7012-9817
  • Santana, Gemina
  • Martínez, Ana
  • Ferrer, Lourdes
  • Moreno, Mª José
  • Calbo Sebastián, Esther|||0000-0001-7750-5347
  • Porta, Carolina
  • Smithson, Alex
  • de la Roca Toda, Maria
  • Aliu, Teresa
  • Camps, Susana
  • Ortega, Montserrat
  • Diaz-Brito, Vicens
  • Moreno, Encarna
  • Agusti, Carme
  • Perea Garcia, Miquel
  • Andrés Nieto, Marta|||0000-0001-5267-0039
  • Grau Palafox, Laura
  • Carrera, Raquel
  • Besolí, Anna
  • Horcajada, Juan Pablo|||0000-0001-9873-5459
  • Gonzalez, Cristina
  • Cuquet, Jordi
  • Maldonado López, Demelsa Maria
  • Benítez Díaz, Rosa María|||0000-0001-6972-6094
  • Duch, Mireia
  • Blancas, David
  • Moreno, Esther
  • Villalba, Naiara
  • Martínez, Sara
  • García Flores, Àngels
  • Ferrer, Roser
  • Bisbe, Josep
  • Blascó, Montse
  • Castro Salom, Antoni
  • López, Ana Felisa
  • Espinach Alvarós, Joan
  • Perez, Àngels
  • Castander, David
  • Calaf, Elisabet
  • Clarós, Mercè
  • Bosch Ros, Núria
  • Montardit, Irene
  • Porta, Roser
  • De la Cruz Sol, Pilar
  • Coll Colell, Mª Rosa
  • García Penche Sanches, Rosa
  • Tricas, Josep Maria
  • Redon, Eva
  • Brugués, Montse
  • Linares González, Laura|||0000-0001-5738-631X
  • Cusco, Maria
  • Barrufet, Mª Pilar
  • Vidal, Elena
  • Barbadillo, Sandra
  • Marimón, Mariló
  • Meije, Yolanda
  • Vaqué, Montserrat
  • Laplace Enguinados, M.Rosa
  • Vila, Blanca
  • Coloma, Ana Guadalupe
  • López, Lucrecia
  • Campins Martí, Magda|||0000-0002-8841-6195
  • Almirante Gragera, Benito|||0000-0002-1189-2361
  • Ferrer, Carme
  • Juan Serra, Natalia
  • Farguell Carrera, Josep
  • Milian Sanz, Marta
  • Moise, Alexandra
  • Jiménez Zarate, Ana Mª
  • Eito Navasal, M. Carmen
  • Garcia Ramirez, María Gracia
  • Armario Fernández, Mar
Background: Catheter-related bloodstream infections (CRBSI) are frequent healthcare-associated infections and an important cause of death. Aim: To analyse changes in CRBSI epidemiology observed by the Infection Control Catalan Programme (VINCat). Methods: A cohort study including all hospital-acquired CRBSI episodes diagnosed at 55 hospitals (2007-2019) in Catalonia, Spain, was prospectively conducted. CRBSI incidence rates were adjusted per 1,000patientdays. To assess the CRBSI rate trend per year, negative binomial models were used, with the number of events as the dependent variable, and the year as the main independent variable. From each model, the annual rate of CRBSI diagnosed per 1,000patientdays and the incidence rate ratio (IRR) with its 95% confidence intervals (CI) were reported. Results: During the study, 9,290 CRBSI episodes were diagnosed (mean annual incidence rate:0.20episodes/1,000patientdays). Patients' median age was 64.1years; 36.6% (3,403/9,290) were female. In total, 73.7% (n=6,845) of CRBSI occurred in non-intensive care unit (ICU) wards, 62.7% (n=5,822) were related to central venous catheter (CVC), 24.1% (n=2,236) to peripheral venous catheters (PVC) and 13.3% (n=1,232) to peripherally-inserted central venous catheters (PICVC). Incidence rate fell over the study period (IRR:0.94;95%CI:0.93-0.96), especially in the ICU (IRR:0.88;95%CI:0.87-0.89). As a whole, while episodes of CVC CRBSI fell significantly (IRR:0.88;95%CI:0.87-0.91), peripherally-inserted catheter CRBSI (PVC and PICVC) rose, especially in medical wards (IRR PICVC:1.08;95%CI:1.05-1.11; IRR PVC: 1.03; 95% 1.00-1.05). Conclusions: Over the study, CRBSIs associated with CVC and diagnosed in ICUs decreased while episodes in conventional wards involving peripherally-inserted catheters increased. Hospitals should implement preventive measures in conventional wards.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effects of the COVID-19 Pandemic on Incidence and Epidemiology of Catheter-Related Bacteremia, Spain

  • Gasch, Oriol|||0000-0001-8518-458X
  • Badia Cebada, Laia|||0000-0002-9321-8492
  • Carmezim, João
  • Vaqué, Montserrat
  • Pomar, Virginia|||0000-0002-8473-5834
  • Moreno, Encarna
  • Marrón, Anna
  • Jiménez Martínez, Emili
  • García Quesada, María José|||0000-0002-0206-7597
  • Garcia Alarcón, Xavier
  • Domènech, Dolors
  • Càmara, Jordi|||0000-0002-0817-0931
  • Andrés Nieto, Marta|||0000-0001-5267-0039
  • Peñafiel, Judith|||0009-0006-6688-6395
  • Porrón, Rosario
  • Limón, Enric|||0000-0002-5396-1521
  • Calbo Sebastián, Esther|||0000-0001-7750-5347
  • Pujol, Miquel|||0000-0002-6475-6208
We compared hospital-acquired catheter-related bacteremia (CRB) episodes diagnosed at acute care hospitals in Catalonia, Spain, during the COVID-19 pandemic in 2020 with those detected during 2007-2019. We compared the annual observed and predicted CRB rates by using the negative binomial regression model and calculated stratified annual root mean squared errors. A total of 10,030 episodes were diagnosed during 2007-2020. During 2020, the observed CRB incidence rate was 0.29/10 patient-days, whereas the predicted CRB rate was 0.14/10 patient-days. The root mean squared error was 0.153. Thus, a substantial increase in hospital-acquired CRB cases was observed during the COVID-19 pandemic in 2020 compared with the rate predicted from 2007-2019. The incidence rate was expected to increase by 1.07 (95% CI 1-1.15) for every 1,000 COVID-19-related hospital admissions. We recommend maintaining all CRB prevention efforts regardless of the coexistence of other challenges, such as the COVID-19 pandemic.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A New Integrative and Mobilizable Element Is a Major Contributor to Tetracycline Resistance in Streptococcus dysgalactiae subsp. equisimilis

  • López de Egea, Guillem|||0000-0002-4196-7627
  • Gonzalez Diaz, Aida|||0000-0002-8326-1307
  • Guédon, Gérard|||0000-0002-5289-3803
  • Lao, Julie
  • Berbel, Dàmaris|||0000-0002-3689-3360
  • Casabella Pernas, Antonio|||0000-0002-2534-3689
  • Marimón, José María|||0000-0002-2787-7094
  • Cercenado, Emilia|||0000-0002-5279-3773
  • Fernández-Delgado, Lucía|||0000-0001-8815-0967
  • Chiapello, Hélène
  • Lacroix, Thomas|||0000-0002-6708-5809
  • Domínguez, María Ángeles
  • Leblond-Bourget, Nathalie|||0000-0001-5739-1370
  • Ardanuy, Carmen|||0000-0003-0225-607X
Tetracycline resistance in streptococci is mainly due to ribosomal protection mediated by the tet (M) gene that is usually located in the integrative and conjugative elements (ICEs) of the Tn 916 -family. In this study, we analyzed the genes involved in tetracycline resistance and the associated mobile genetic elements (MGEs) in Streptococcus dysgalactiae subsp. equisimilis (SDSE) causing invasive disease. SDSE resistant to tetracycline collected from 2012 to 2019 in a single hospital and from 2018 in three other hospitals were analyzed by whole genome sequencing. Out of a total of 84 SDSE isolates, 24 (28.5%) were resistant to tetracycline due to the presence of tet (M) (n = 22), tet (W) (n = 1), or tet (L) plus tet (W) (n = 1). The tet (M) genes were found in the ICEs of the Tn 916 -family (n = 10) and in a new integrative and mobilizable element (IME; n = 12). Phylogenetic analysis showed a higher genetic diversity among the strains carrying Tn 916 than those having the new IME, which were closely related, and all belonged to CC15. In conclusion, tetracycline resistance in SDSE is mostly due to the tet (M) gene associated with ICEs belonging to the Tn 916 -family and a new IME. This new IME is a major cause of tetracycline resistance in invasive Streptococcus dysgalactiae subsp. equisimilis in our settings.